CVRF
  • Login
  • Register
  • CVRF's Meetings
    TCTAP AP VALVES & SH COMPLEX PCI

SummitMD SummitMD

TCTAP 2023
  • Home
  • News
    • SummitMD News
    • Conference News
      • TCTAP
      • AP VALVES & SH
      • COMPLEX PCI
      • ACT PROGRAM
  • Videos
    • TCTAP
    • AP VALVES & SH
    • COMPLEX PCI
    • ACT PROGRAM
  • Slides
    • Coronary
    • Endovascular
    • Structural Heart Disease
    • Valve
    • Imaging & Physiology
    • Pharmacology
  • Book
  • Conferences
    • TCTAP
    • AP VALVES & STRUCTURAL HEART
    • COMPLEX PCI
  • About CVRF
    • Mission
    • Board Members
    • R&D Divisions
      • Clinical Research Coordinating Center
      • Translational Research Center
      • Research Activity
      • Paper Publication
    • Education
      • ACT Program
      • Website

Presenter's Information

  • Home
  • Slides

Young-Hoon Jeong , MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  • Slide Presentations
  1. The Benefit of High Intensity Atorvastatin/Ezetimine Combination Therapy in Coronary Risk Patients with Hypercholesterolemia
  2. [TCTAP A-033] Reappraisal of Pharmacodynamic Effect of Adjunctive Cilostazol and High-dos Clopidogrel in East Asian ACS Patients
  3. Update on Relationship Between Platelet Reactivity and Clinical Outcomes: How to Select Optimal Patients for Prasugrel?
  4. Is Potent Oral P2Y12 Inhibitor Enough to Prevent Thrombotic Events in High-risk PCI Patients?
  5. ACCEL-LOADING-ACS (ACCELerated Inhibition of Platelet Aggregation, Inflammation and Myonecrosis by Adjunctive Cilostazol LOADING in Patients with Acute Coronary Syndrome) Trial
  6. The Limits of Platelet Oriented Treatment : Cilostazol as Multidisciplinary Approach
  7. The Role of Triple Antiplatelet Therapy in Patients with High Risk
  8. The Role of Triple Antiplatelet Therapy in Patients with High Risk
Conference Slides
  • TCTAP
  • AP VALVES & SH
  • COMPLEX PCI
Category

Coronary

  • Left Main
  • Bifurcation
  • CTO
  • Long Lesion
  • Ostial
  • In-stent Restenosis
  • Others

Endovascular

  • Carotid
  • Peripheral Disease
    • SFA
    • BTK
    • Iliac
    • Poplitial
    • Subclavian
  • Abdominal Aorta
  • Renal
  • Others

Structural Heart Disease

  • Congenital Heart Disease
  • HOCM
  • Others

Valve

  • TAVR
  • Others

Imaging & Physiology

  • Antiplatelet
  • Anticoagulant
  • Lipid and Inflammation
  • Others

Pharmacology

  • Antiplatelet
  • Anticoagulant
  • Lipid and Inflammation
  • Others

  • Upcoming Events
  • 28th
    TCTAP 2023
    May 6-9, 2023
    Grand Walkerhill Seoul, Korea
  • 12th
    AP VALVES & SH 2023
    August 10-11, 2023
    Grand Walkerhill Seoul, Korea
  • 8th
    COMPLEX PCI 2023
    November 23-24, 2023
    Grand Walkerhill Seoul, Korea
CVRF
CardioVascular Research Foundation
Àç´Ü¹ýÀÎ ½ÉÀåÇ÷°ü¿¬±¸Àç´Ü
2F Asan Institute for Education & Research
88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul 05505, Korea
´ëÇ¥ÀÚ: ¹Ú½ÂÁ¤ | ÀüÈ­¹øÈ£: 02-3010-4720
»ç¾÷ÀÚµî·Ï¹øÈ£: 215-82-06387

Privacy Policy

The Latest News
  • Extended BEST trial offers insight into murky dispute over optimal long-term revasc strategy in MVCAD
    23-01-06
  • TAVI noninferior to surgery for elderly, severe AS patients at moderate operative risk: UK TAVI
    22-10-14
  • [DOWNLOAD FREE EBOOK] Technical Forum A to Z: Complex Coronary Intervention - 3rd Edition
    22-10-7
Porto Website Template

Copyright 2002. All Rights Reserved.